```html

Herpes Simplex Virus Infection – A Complete Medical Guide

Overview

Herpes simplex virus (HSV) infection is one of the most common viral infections worldwide. Two closely related viruses cause disease in humans:

• HSV‑1 – traditionally associated with oral lesions (cold sores) but can also cause genital disease.
• HSV‑2 – primarily transmitted sexually and the leading cause of genital herpes.

Both viruses are lifelong, meaning once infected the virus remains dormant in nerve cells and can reactivate.

Who is affected?

HSV can infect anyone who is exposed, regardless of age, gender, or ethnicity. However, certain groups have higher prevalence:

• Adults aged 14‑49: the most common age group for genital HSV‑2 infection.
• People with multiple sexual partners or a history of other sexually transmitted infections (STIs).
• Individuals with weakened immune systems (e.g., HIV, organ‑transplant recipients).

Global prevalence

According to the World Health Organization (WHO), an estimated 67% of the global population under 50 years old is infected with HSV‑1, while 13% of adults aged 15‑49 carry HSV‑2 <sup>1</sup>. In the United States, the CDC reports that about 1 in 6 people aged 14‑49 have genital HSV‑2 infection <sup>2</sup>.

Symptoms

Many people with HSV never notice symptoms, especially with HSV‑1 oral infection. When symptoms do appear, they usually fall into two phases: primary (first) outbreak and recurrent episodes.

Primary (initial) outbreak

• Prodrome – tingling, itching, or burning sensation 1‑2 days before lesions appear.
• Skin lesions – painful vesicles (small fluid‑filled blisters) that break open and crust over. Common sites:
  • Oral/lips (HSV‑1)
  • Genitals, buttocks, thighs, or anus (HSV‑2)
• Systemic symptoms – fever, headache, muscle aches, swollen lymph nodes, and malaise. These are more common in first episodes, especially in children.
• Urinary retention – painful urination or difficulty emptying the bladder (more common in genital HSV‑2 in women).

Recurrent (reactivation) episodes

• Typically milder, shorter (5‑10 days), and may be preceded by a milder prodrome.
• Lesions may be few in number and often heal without scarring.
• Some individuals experience “asymptomatic shedding” – virus is present on the skin/mucosa without visible sores, allowing transmission.

Other possible manifestations

• Herpes keratitis – HSV infection of the cornea, causing eye pain, redness, and may lead to vision loss if untreated.
• Eczema herpeticum – widespread HSV infection superimposed on eczema or atopic dermatitis.
• Neonatal herpes – severe infection in newborns, usually acquired during delivery from an infected mother.
• Herpes encephalitis – rare but life‑threatening inflammation of the brain, most often caused by HSV‑1.

Causes and Risk Factors

HSV is a DNA virus transmitted through direct contact with infected skin or mucous membranes.

Transmission pathways

• Oral‑to‑oral – kissing, sharing utensils, or lip‑licking.
• Oral‑to‑genital – oral sex can spread HSV‑1 to the genital area.
• Genital‑to‑genital – vaginal, anal, or oral sexual contact transfers HSV‑2.
• Vertical transmission – mother to infant during childbirth (particularly with HSV‑2).

Key risk factors

• Multiple or new sexual partners.
• History of other STIs (e.g., chlamydia, gonorrhea, HIV).
• Engaging in unprotected sex (condom use reduces but does not eliminate risk).
• Weakened immune system – medications (e.g., corticosteroids, biologics) or conditions (e.g., HIV, cancer).
• Skin disruption – cuts, abrasions, or eczema can facilitate viral entry.
• Pregnancy – hormonal changes may increase susceptibility to reactivation.

Diagnosis

Accurate diagnosis helps guide treatment and counseling.

Clinical evaluation

• Physical examination of lesions – classic grouped vesicles on an erythematous base are highly suggestive.
• Medical history – prior outbreaks, sexual history, and possible exposures.

Laboratory tests

1. Polymerase chain reaction (PCR) – detects HSV DNA from swabs of lesions, cerebrospinal fluid (for encephalitis), or blood. PCR is the most sensitive method and can differentiate HSV‑1 from HSV‑2.
2. Viral culture – older method; less sensitive, especially when lesions are healing.
3. Serology (blood antibodies) – IgM indicates recent infection; IgG indicates past exposure. Helpful when lesions are absent but patient seeks confirmation of prior exposure.
4. Tzanck smear – microscopic examination of lesion scrapings for multinucleated giant cells. Now rarely used due to low specificity.

When to order tests

• First episode with atypical appearance.
• Pregnant women with genital lesions (to guide delivery planning).
• Immunocompromised patients with severe or disseminated disease.
• Suspected HSV encephalitis – immediate PCR of CSF is critical.

Treatment Options

There is no cure for HSV; treatment aims to shorten outbreaks, reduce symptom severity, and limit transmission.

Antiviral medications

Drug	Typical Dosage (Adults)	Use
Acyclovir	200 mg 5×/day (oral) or 5 mg/kg IV q8h	First‑line for primary & recurrent episodes, neonatal & encephalitis treatment.
Valacyclovir	1 g twice daily (oral) for 7‑10 days (primary); 500 mg daily suppressive therapy.	Improved bioavailability; preferred for suppressive therapy.
Famciclovir	250 mg three times daily (oral) for 7‑10 days.	Alternative oral agent.

Suppressive therapy (daily antiviral) is recommended for:

• ≥4 outbreaks per year.
• Patients with genital HSV who wish to reduce transmission to partners.
• Immunocompromised individuals.

Topical treatments

• Topical acyclovir cream may provide modest symptom relief if started within 24 hours, but oral therapy is more effective.

Procedural interventions

• Laser or cryotherapy – occasionally used for recurrent oral lesions that are painful or cosmetically concerning, though not a substitute for antivirals.

Lifestyle and supportive measures

• Keep affected area clean and dry; avoid picking at lesions.
• Use over‑the‑counter pain relievers (acetaminophen or ibuprofen).
• Apply cool compresses to reduce discomfort.
• Consider using a lip balm with sunscreen to prevent UV‑triggered oral recurrences.

Living with Herpes Simplex Virus Infection

Although a diagnosis can be emotionally challenging, most people lead normal lives.

Daily management tips

• Identify triggers – stress, fatigue, illness, menstrual cycle, and excessive sun exposure often precede recurrences. Keeping a symptom diary can help you anticipate outbreaks.
• Prompt treatment – start antivirals at the first sign of prodrome. Early therapy shortens lesion duration by 1‑2 days.
• Safe sexual practices – use condoms or dental dams; disclose HSV status to partners.
• Personal hygiene – wash hands thoroughly after touching lesions; avoid sharing towels, razors, or lip products during an outbreak.
• Pregnancy planning – women with genital HSV should discuss suppressive therapy with obstetricians to reduce the risk of neonatal transmission.
• Psychological support – counseling, support groups, or reputable online communities can mitigate anxiety and stigma.

Impact on quality of life

Studies show that consistent antiviral therapy improves mental health scores and sexual satisfaction for many patients <sup>3</sup>. Open communication with healthcare providers and partners is key to reducing distress.

Prevention

While lifelong infection cannot be eliminated, transmission can be minimized.

• Abstinence or mutually monogamous relationships with an uninfected partner.
• Consistent condom use – reduces but does not completely prevent genital HSV transmission (risk reduction ≈30‑50%).
• Antiviral suppressive therapy for an infected partner – reduces transmission to an uninfected partner by ~50% (clinical trial data).
• Avoid sexual activity during active lesions or prodrome.
• Limit oral contact when you have a cold sore; avoid kissing infants or pregnant women.
• Vaccination research – No approved HSV vaccine yet, but several candidates are in Phase III trials (NIH, 2023).

Complications

Most HSV infections are self‑limited, yet complications can be serious, especially in vulnerable populations.

Common complications

• Secondary bacterial infection of lesions – may require antibiotics.
• Genital scarring – recurrent ulceration can lead to adhesions or dyspareunia.
• Psychosocial impact – anxiety, depression, and relationship strain.

Severe complications

• Neonatal herpes – occurs in 1‑2 per 10,000 births; mortality >30% without treatment.
• Herpes encephalitis – mortality 10‑20% despite antiviral therapy; early PCR diagnosis is crucial.
• Ocular disease – recurrent keratitis may lead to corneal scarring and vision loss.
• Disseminated infection in immunocompromised hosts – can involve liver, lungs, or skin.

When to Seek Emergency Care

References

1. World Health Organization. “Herpes simplex virus.” WHO Fact Sheet, 2022. https://www.who.int
2. Centers for Disease Control and Prevention. “Genital Herpes – CDC Fact Sheet.” 2023. https://www.cdc.gov
3. Stanley, M. et al. “Impact of Suppressive Antiviral Therapy on Quality of Life in Persons with Genital Herpes.” *JAMA Dermatology*, 2021;157(4):468‑475.
4. Mayo Clinic. “Herpes simplex virus infection.” 2024. https://www.mayoclinic.org
5. Cleveland Clinic. “Herpes Encephalitis.” 2023. https://my.clevelandclinic.org
6. National Institutes of Health. “Herpes Simplex Virus Vaccine Development.” NIH News Release, 2023.

```